Literature DB >> 27923023

Diversity and collaboration for effective immunotherapy.

Karolina Palucka1, Jacques Banchereau1.   

Abstract

Mesh：

Year:  2016        PMID： 27923023     DOI： 10.1038/nm.4249

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

Review 1.  The future of immune checkpoint therapy.

Authors:  Padmanee Sharma; James P Allison
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 2.  The varieties of immunological experience: of pathogens, stress, and dendritic cells.

Authors:  Bali Pulendran
Journal:  Annu Rev Immunol       Date:  2015-02-04       Impact factor: 28.527

3.  SnapShot: cancer vaccines.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

Review 4.  The Basis of Oncoimmunology.

Authors:  A Karolina Palucka; Lisa M Coussens
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

5.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean Jacques Grob; C Lance Cowey; Christopher D Lao; Dirk Schadendorf; Reinhard Dummer; Michael Smylie; Piotr Rutkowski; Pier F Ferrucci; Andrew Hill; John Wagstaff; Matteo S Carlino; John B Haanen; Michele Maio; Ivan Marquez-Rodas; Grant A McArthur; Paolo A Ascierto; Georgina V Long; Margaret K Callahan; Michael A Postow; Kenneth Grossmann; Mario Sznol; Brigitte Dreno; Lars Bastholt; Arvin Yang; Linda M Rollin; Christine Horak; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

Review 6.  Immune Checkpoint Blockade in Cancer Therapy.

Authors:  Michael A Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

7.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.

Authors:  Philip D Greenberg; Sunil R Hingorani; Ingunn M Stromnes; Thomas M Schmitt; Ayaka Hulbert; J Scott Brockenbrough; Hieu Nguyen; Carlos Cuevas; Ashley M Dotson; Xiaoxia Tan; Jennifer L Hotes
Journal:  Cancer Cell       Date:  2015-10-29       Impact factor: 31.743

Review 8.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.

Authors:  Suzanne L Topalian; Janis M Taube; Robert A Anders; Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

9.  Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Authors:  Kai Hildner; Brian T Edelson; Whitney E Purtha; Mark Diamond; Hirokazu Matsushita; Masako Kohyama; Boris Calderon; Barbara U Schraml; Emil R Unanue; Michael S Diamond; Robert D Schreiber; Theresa L Murphy; Kenneth M Murphy
Journal:  Science       Date:  2008-11-14       Impact factor: 47.728
  9 in total
  3 in total

Review 1.  Synthetic nanovaccines for immunotherapy.

Authors:  Min Luo; Layla Z Samandi; Zhaohui Wang; Zhijian J Chen; Jinming Gao
Journal:  J Control Release       Date:  2017-03-21       Impact factor: 9.776

2.  Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids.

Authors:  Akihiro Tokunaga; Daisuke Sugiyama; Yuka Maeda; Allison Betof Warner; Katherine S Panageas; Sachiko Ito; Yosuke Togashi; Chika Sakai; Jedd D Wolchok; Hiroyoshi Nishikawa
Journal:  J Exp Med       Date:  2019-09-19       Impact factor: 14.307

Review 3.  Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting.

Authors:  Alexey V Baldin; Lyudmila V Savvateeva; Alexandr V Bazhin; Andrey A Zamyatnin
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.